Every Form 4 that Microvision (MVIS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MVIS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MVIS filings page.
MICROVISION, INC. (MVIS) reported that its Chief Financial Officer, Christine Chambers, received a grant of 562,114 Restricted Stock Units on September 2, 2026. The RSUs convert into common stock on a unit-for-share basis without payment and are scheduled to vest in four equal annual installments from August 27, 2027 through August 27, 2030, contingent on continued service.
MICROVISION, INC. (MVIS) reported that Chief Commercial Officer Jeemyung Byun received a grant of 674,536 Restricted Stock Units (RSUs)unit-for-share basis without payment and are scheduled to vest in four equal annual installments on July 20, 2027, 2028, 2029, and 2030, contingent on continued service through each vesting date. No transactions were made under a Rule 10b5-1 trading plan.
MICROVISION, INC. (MVIS) director Jada Smith reported the vesting and conversion of 4,670 Restricted Stock Units into an equal number of shares of common stock on September 1, 2026. After this transaction, Smith directly holds 16,440 shares of MicroVision common stock.
The RSUs were granted on July 16, 2026 and are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision’s 2027 Annual Meeting of Stockholders, contingent on continued board service. No Rule 10b5-1 trading plan is reported.
MICROVISION, INC. (MVIS) director Robert Paul Carlile reported the vesting and settlement of restricted stock units into common stock. On September 1, 2026, 4,670 RSUs were converted on a unit-for-share basis into 4,670 shares of common stock at no cash cost, increasing his directly held common shares to 42,051. The corresponding RSU derivative position was reduced to zero. No Rule 10b5-1 trading plan is reported.
Footnotes state these RSUs are part of a grant made on July 16, 2026 that is scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision’s 2027 Annual Meeting of Stockholders, with the original grant of 280,152 RSUs on a pre-split basis equating to 18,677 RSUs on a post-split basis.
MICROVISION, INC. (MVIS) director Jeffrey A. Herbst reported the vesting and conversion of 4,670 Restricted Stock Units into the same number of shares of common stock on September 1, 2026, on a unit-for-share basis. Following this RSU distribution, Herbst directly holds 23,398 shares of MicroVision common stock. The RSUs are part of a grant of 18,677 post-split RSUs scheduled to vest in four equal quarterly installments through around the first anniversary of the July 16, 2026 grant date, assuming continued board service, and no Rule 10b5-1 trading plan is reported.
MICROVISION, INC. (MVIS) director Laura J. Peterson reported the vesting and settlement of restricted stock units into common shares. On September 1, 2026, 4,670 RSUs were exercised on a unit-for-share basis and distributed as 4,670 shares of common stock without payment. Following this distribution, Peterson holds 11,977 shares of common stock directly, and the specific RSU award reported in this filing now shows no remaining derivative balance. No Rule 10b5-1 trading plan is reported.
MICROVISION, INC. (MVIS) director Peter Schabert reported the vesting and exercise of 4,670 Restricted Stock Units into an equal number of shares of common stock on September 1, 2026. The RSUs converted to common stock on a unit-for-share basis without payment, bringing his direct common stock holdings to 15,902 shares. No Rule 10b5-1 trading plan is reported for these transactions.
Smith Jada reported acquisition or exercise transactions in this Form 4 filing.
MicroVision director Jada Smith received an equity grant of 280,152 Restricted Stock Units (RSUs) on 07/16/2026. Each RSU represents a contingent right to receive one share of MicroVision common stock. The RSUs are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the issuer's 2027 Annual Meeting of Stockholders, subject to her continued board service. Following this grant, she holds 280,152 RSUs directly.
Schabert Peter reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. director Peter Schabert received a grant of 280,152 restricted stock units (RSUs) on July 16, 2026. Each RSU represents one share of common stock and will vest in four equal quarterly installments until the earlier of the first anniversary of the grant or the day before the 2027 annual stockholders meeting, contingent on his continued board service.
Peterson Laura J. reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. granted its director Laura J. Peterson 280,152 Restricted Stock Units (RSUs) on July 16, 2026. Each RSU represents a right to receive one share of common stock and will vest in four equal quarterly installments, becoming fully vested on the earlier of the first anniversary of the grant or the day prior to the 2027 Annual Meeting of Stockholders, contingent on her continued board service. Following this award, Peterson directly holds 280,152 RSUs.
Herbst Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. granted director Jeffrey A. Herbst 280,152 restricted stock units (RSUs), each representing one share of common stock. These RSUs vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the July 16, 2026 grant or the day before the 2027 annual stockholders meeting, contingent on his continued board service.
Carlile Robert Paul reported acquisition or exercise transactions in this Form 4 filing.
MicroVision, Inc. director Robert Paul Carlile received a grant of 280,152 Restricted Stock Units (RSUs) on July 16, 2026. Each RSU represents a contingent right to receive one share of MicroVision common stock. The RSUs vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision's 2027 Annual Meeting of Stockholders, subject to his continued board service. Following this grant, he directly holds 280,152 RSUs.
MICROVISION, INC. director and CEO Glen W. DeVos reported a tax-related share disposition. The issuer completed a nondiscretionary sell-to-cover transaction tied to an equity award, withholding and selling 183,233 shares of common stock at a weighted average price of $0.3621 per share, in multiple trades between $0.3509 and $0.3779. After this tax-withholding event, DeVos directly holds 537,937 shares of MicroVision common stock.
MicroVision, Inc. General Counsel Drew G. Markham reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On June 8, 2026, vested RSUs converted into 118,800 shares of common stock on a unit-for-share basis, and a further 150,000 RSUs were granted.
The filing shows a separate 150,000 RSU award approved under the 2025 Executive Bonus Plan, scheduled to vest in thirds annually through June 6, 2028, contingent on continued employment. On June 10, 2026, 77,905 shares were withheld and sold by the issuer at a weighted average price of $0.3621 per share to satisfy tax obligations.
Following these transactions, Markham directly holds 663,203 shares of MicroVision common stock and 150,000 RSUs. The activity reflects derivative exercises, an RSU grant, and a nondiscretionary, tax-related sell-to-cover event rather than open-market buying or selling.
MicroVision, Inc. CEO Glen W. DeVos reported equity compensation activity on June 8, 2026. He exercised vested restricted stock units (RSUs) to acquire 361,500 shares of common stock on a unit-for-share basis, without paying cash.
On the same date, he was granted 361,500 new RSUs tied to common stock. Following these transactions, DeVos directly holds 721,170 shares of common stock and 361,500 RSUs. These are compensation-related awards rather than open-market purchases or sales.
MicroVision interim CFO Stephen Hrynewich reported routine equity compensation activity. On June 5, vested restricted stock units converted into 6,000 shares of common stock distributed without payment on a unit-for-share basis. On June 8, 2,017 shares were disposed of in a withholding tax-related, nondiscretionary sell-to-cover transaction completed by the company under the award terms. After these transactions, Hrynewich directly holds 182,497 shares of common stock, and the reported RSU grant has been fully converted.
MICROVISION, INC. General Counsel Drew G. Markham exercised previously granted restricted stock units that vested into 119,880 shares of common stock, converting the RSUs on a unit-for-share basis without cash payment. In connection with this vesting, 35,901 shares were disposed of through a tax-withholding, nondiscretionary sell-to-cover transaction completed by the company under the award terms at a weighted average price of $0.3850–$0.3852 per share. After these compensation-related transactions, Markham directly holds 472,308 shares of common stock, and the specific RSU award referenced in the filing is fully converted.
MICROVISION, INC. director Jada Smith exercised vested restricted stock units, receiving 22,007 shares of common stock on a unit-for-share basis without payment. These shares came from restricted stock units that vested and converted into common stock. After the transaction, she directly holds 176,550 common shares.
MicroVision, Inc. director Peter Schabert increased his direct common stock holdings through RSU vesting. On June 5, 2026, 22,007 vested restricted stock units were distributed to him, without payment, as 22,007 shares of common stock on a unit-for-share basis.
These shares arose from restricted stock units that, at vesting, convert into common stock on a unit-for-share basis. After this transaction, Schabert directly owned 168,478 shares of MicroVision common stock. No open-market purchases or sales were reported in this filing.
MICROVISION, INC. director Robert Paul Carlile reported the vesting of restricted stock units that were settled in common stock. On this Form 4, 22,007 Restricted Stock Units converted into 22,007 shares of common stock at a stated price of $0.00 per share, reflecting a compensation-related equity award rather than an open-market trade. After this distribution, he directly holds 560,706 shares of common stock. Footnotes explain that the RSUs convert on a unit-for-share basis and clarify that a prior Form 4 had misstated the total RSUs granted, with the current vesting calculated using the corrected grant amount.
MicroVision, Inc. Executive Vice Chair and director Simon Biddiscombe received 22,007 shares of common stock through the vesting and conversion of an equal number of restricted stock units. The RSUs vested and were distributed without payment, bringing his directly held common shares to 407,256 after the transaction.
MICROVISION, INC. director Laura J. Peterson acquired 18,005 shares of common stock through the vesting and distribution of restricted stock units. The RSUs were delivered on a unit-for-share basis without payment, effectively converting compensation awards into stock. Following this transaction, she directly holds 109,601 common shares.
MicroVision, Inc. director Jeffrey A. Herbst increased his shareholdings through routine equity compensation. On June 5, 2026, 22,007 Restricted Stock Units (RSUs) vested and were distributed to him, without payment, as 22,007 shares of common stock on a unit-for-share basis. After this RSU-to-share conversion, he directly holds 280,919 shares of MicroVision common stock. A footnote explains that an earlier Form 4 had misstated the size of the original RSU grant and that the vesting reported here is based on the corrected grant amount.
MicroVision interim CFO Stephen Hrynewich reported routine equity compensation activity involving restricted stock units (RSUs). On May 5, 2026, 4,800 RSUs vested and converted into the same number of shares of common stock on a unit-for-share basis, without cash payment. On May 6, 2026, 1,623 of these shares were disposed of through a tax-related, nondiscretionary sell-to-cover transaction completed by the company at a weighted average price of $0.6447 per share, with trades ranging from $0.6429 to $0.6451. After these transactions, Hrynewich directly holds 178,514 shares of MicroVision common stock.
MicroVision Interim CFO Stephen Hrynewich reported routine equity compensation activity. On April 6, 2026, vested restricted stock units (RSUs) converted into 4,800 shares of common stock on a unit-for-share basis, without cash payment.
On April 8, 2026, the company completed a tax-related, nondiscretionary sell-to-cover transaction, withholding 1,555 shares of common stock at a weighted average price of $0.6289 per share to satisfy tax obligations under the award agreement. Following these transactions, Hrynewich directly owns 175,337 shares of MicroVision common stock.
MICROVISION, INC. CEO Glen W. DeVos reported routine equity compensation activity involving restricted stock units and related tax withholding. On March 31, 2026, 325,000 vested restricted stock units converted into an equal number of common shares. On April 2, 2026, the company completed a tax-related nondiscretionary sell-to-cover transaction, withholding 153,230 common shares at a weighted average price of $0.6403 per share in multiple trades between $0.6402 and $0.6408. Following these transactions, DeVos directly holds 359,670 shares of MicroVision common stock. The filing reflects compensation vesting and tax settlement rather than open-market buying or selling by the CEO.
MicroVision, Inc. Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of the company’s common stock on March 15, 2026. The shares were purchased directly from MicroVision under a Subscription Agreement at $0.5322 per share, the closing price on March 13, 2026, in a transaction intended to be exempt under Rule 16b-3. Following this acquisition, Biddiscombe directly holds 385,249 MicroVision shares.
MicroVision director Jeffrey A. Herbst acquired 28,185 shares of common stock directly from the company at $0.5322 per share under a Subscription Agreement executed on March 15, 2026. The purchase price matched the closing share price on March 13, 2026 and is intended to qualify as an exempt transaction under Rule 16b-3. Following this acquisition, Herbst directly holds 258,912 shares of MicroVision common stock.
MicroVision director Robert Paul Carlile acquired additional shares of the company’s common stock. On March 15, he obtained 187,900 shares directly from MicroVision under a Subscription Agreement at $0.5322 per share, matching the March 13 closing price. This increased his direct holdings to 538,699 shares. The purchase is intended to qualify as an exempt transaction under Rule 16b-3, meaning it is structured within specific insider trading exemption rules rather than as an open-market trade.
MicroVision director Laura J. Peterson acquired 37,580 shares of common stock from the company under a subscription agreement. The shares were purchased directly from MicroVision at a price of $0.5322 per share, matching the closing price on March 13, 2026.
After this exempt Rule 16b-3 transaction, Peterson directly holds 91,596 MicroVision shares. This reflects a compensation-related or insider-aligned acquisition rather than an open-market trade.
MicroVision, Inc. CEO Glen W. DeVos reported an acquisition of company stock. On March 15, 2026, he acquired 187,900 shares of MicroVision common stock directly from the company at $0.5322 per share under a Subscription Agreement, matching the March 13, 2026 closing price.
Following this transaction, DeVos directly holds 187,900 shares. A footnote states the purchase is intended to be an exempt transaction pursuant to Rule 16b-3.
MicroVision director Jada Smith acquired 28,185 shares of common stock directly from the company in a subscription transaction. The shares were purchased at $0.5322 per share, matching the closing price of MicroVision stock on March 13, 2026.
After this grant/award acquisition, Smith directly owns 154,543 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions with the issuer.
MicroVision, Inc. general counsel Drew G. Markham acquired 9,395 shares of common stock directly from the company on March 15, 2026. The purchase price was $0.5322 per share, matching the closing price on March 13, 2026 as set by a subscription agreement.
Following this transaction, Markham directly holds 388,329 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which generally covers certain insider transactions approved under specific governance procedures.
MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company. The shares were purchased at $0.5322 per share, matching the closing price on March 13, 2026, under a Subscription Agreement executed on March 15, 2026.
After this acquisition, Hrynewich directly holds 172,092 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions for reporting and short-swing profit purposes.
MICROVISION, INC. interim CFO Stephen Hrynewich reported equity compensation activity and related tax withholding. On March 5, 2026, 4,800 restricted stock units vested and converted on a unit-for-share basis into 4,800 shares of common stock at no cash cost to him.
These shares increased his directly held common stock to 164,256 shares. On March 6, 2026, 1,559 of those shares were disposed of through a withholding, nondiscretionary sell-to-cover transaction completed by the company to satisfy tax obligations, leaving him with 162,697 directly owned shares.
MICROVISION, INC. director Robert Paul Carlile reported the vesting and conversion of restricted stock units into common shares. On this date, 22,007 RSUs were exercised at no cost and settled into 22,007 shares of common stock, bringing his directly held common stock to 350,799 shares.
The footnotes explain that RSUs convert into common stock on a unit-for-share basis without payment and clarify that a prior Form 4 understated the original RSU grant, with vesting now calculated from the corrected 88,028-unit grant.
MICROVISION, INC. director Laura J. Peterson reported the vesting of restricted stock units and their conversion into common shares. On March 2, 2026, 18,005 restricted stock units were exercised on a unit-for-share basis without payment, converting into 18,005 shares of common stock. After this conversion, Peterson directly owned 54,016 shares of MICROVISION common stock. The footnotes explain that RSUs convert into shares without cash outlay at vesting and that a separate RSU grant dated July 22, 2025 is scheduled to vest in four equal quarterly installments, subject to her continued board service.
MicroVision director Peter Schabert reported the vesting of restricted stock units that were converted into common shares. On the transaction date, 22,007 RSUs were distributed without payment and converted into 22,007 shares of common stock. Following this derivative exercise, he directly owns 146,471 common shares. A footnote explains that an earlier Form 4 had misstated the total RSUs granted in June 2025, and this vesting is based on the corrected grant amount.
MICROVISION, INC. director Jada Smith reported the vesting of restricted stock units that converted into common shares. On March 2, 2026, 22,007 RSUs were exercised at $0.00 per unit into 22,007 shares of common stock, bringing her direct common stock holdings to 126,358 shares.
MICROVISION, INC. director Jeffrey A. Herbst reported the vesting of 22,007 restricted stock units, which were converted into an equal number of common shares without payment on a unit-for-share basis. Following this non-cash derivative exercise, he directly holds 230,727 shares of common stock. A prior Form 4 is corrected here to state that the RSU grant on 06/05/2025 was 88,208 units, and the vesting disclosed was calculated from this corrected amount.
MICROVISION, INC. Executive Vice Chair and director Simon Biddiscombe acquired common shares through vesting of restricted stock units. On March 2, 2026, 22,007 RSUs converted into 22,007 shares of common stock on a unit-for-share basis, without payment. Following this RSU conversion, his direct common stock holdings increased to 291,299 shares. The footnotes note that a prior Form 4 had misstated the total RSUs granted on June 6, 2025, and the vesting reported here is based on the corrected grant amount.
MicroVision interim CFO Stephen Hrynewich reported routine equity award activity. On February 5, 2026, 4,800 vested restricted stock units converted into the same number of shares of common stock at $0.00 per share, increasing his direct holdings to 160,933 shares.
On February 6, 2026, the issuer completed a tax withholding, nondiscretionary sell-to-cover transaction for 1,477 common shares at a weighted average price of $0.704 per share, leaving Hrynewich with 159,456 directly owned shares.
MicroVision, Inc. interim CFO Stephen Hrynewich reported routine equity compensation activity. On January 5, 2026, 4,800 restricted stock units vested and were distributed to him as shares of common stock on a unit-for-share basis at $0.00 per share. These RSUs simultaneously ceased to exist as a derivative position.
On January 6, 2026, the issuer completed a withholding tax-related, nondiscretionary sell-to-cover of 1,573 shares of common stock at a price of $0.9185 per share under the award agreement. After these transactions, Hrynewich directly beneficially owned 156,133 shares of MicroVision common stock.
MicroVision (MVIS) CFO equity activity: Chief Financial Officer Anubhav Verma reported the vesting of restricted stock units and related share activity. On 11/17/2025, 16,765 restricted stock units vested and were converted into the same number of common shares at an exercise price of $0.00. On 11/18/2025, 4,225 common shares were disposed of at $0.941 per share in a tax withholding "sell-to-cover" transaction completed by the company under the award terms.
Following these transactions, Verma beneficially owned 499,438 shares of MicroVision common stock in direct ownership, and no restricted stock units remained from this specific award. The filing notes that the RSUs were distributed on a one-for-one share basis and that the tax sale was nondiscretionary, carried out in accordance with the award agreement.
MicroVision, Inc. reporting person Simon Biddiscombe, an Executive Vice Chair and Director, received a grant of 241,000 restricted stock units (RSUs) on 10/01/2025. The RSUs convert unit-for-share at vesting with no cash payment required, and are scheduled to vest in full on 10/01/2026 provided the reporting person continues service through that date. The Form 4 discloses the transaction date as 10/01/2025 and the filing was signed by an attorney-in-fact on 10/02/2025. The report records direct beneficial ownership of 0 common shares following the grant because the RSUs have not yet vested.